Teleflex Incorporated (TFX) to Issue Quarterly Dividend of $0.34 on March 17th

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend on Thursday, February 27th, RTT News reports. Shareholders of record on Friday, March 7th will be given a dividend of 0.34 per share by the medical technology company on Monday, March 17th. This represents a $1.36 annualized dividend and a yield of 1.03%. The ex-dividend date is Friday, March 7th.

Teleflex has a dividend payout ratio of 8.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Trading Down 4.7 %

NYSE TFX opened at $132.58 on Friday. The stock has a market capitalization of $6.16 billion, a price-to-earnings ratio of 26.36, a PEG ratio of 1.73 and a beta of 1.16. The stock’s 50 day moving average price is $175.44 and its two-hundred day moving average price is $205.04. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex has a 52 week low of $130.60 and a 52 week high of $249.90.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. As a group, analysts anticipate that Teleflex will post 13.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have weighed in on TFX. Truist Financial lowered their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price target for the stock from $220.00 to $155.00 in a research report on Friday. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Wells Fargo & Company lowered their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday. Nine investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $196.83.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.